NG-ALLYL-L-ARGININE AND NG-CYCLOPROPYL-L-ARGININE - 2 NOVEL INHIBITORS OF MACROPHAGE NITRIC-OXIDE SYNTHASE

被引:75
作者
OLKEN, NM [1 ]
MARLETTA, MA [1 ]
机构
[1] UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109
关键词
D O I
10.1021/jm00084a020
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
N(G)-Methyl-L-arginine has recently been shown to inactivate the inducible murine macrophage nitric oxide (.NO) synthase (Olken, N. M.; Rusche, K. M.; Richards, M. K.; Marletta, M. A. Biochem. Biophys. Res. Commun. 1991, 177, 828-833). N(G)-Allyl-L-arginine and N(G)-cyclopropyl-L-arginine were synthesized as potential mechanism-based enzyme inhibitors to exploit the chemistry presumed to occur at the active site. N(G)-Cyclopropyl-L-arginine was found to be a potent reversible inhibitor with a K(i) = 7.7-mu-M. N(G)-Allyl-L-arginine was found to be both a potent reversible (K(i) = 2.1-mu-M) and irreversible inhibitor of the enzyme. This irreversible inhibition demonstrated pseudo-first-order inactivation kinetics with k(inact) = 0.026 min-1 and K(I) = 3.4-mu-M. Stereospecific protection of the inactivation was afforded by L-arginine, and saturability of the inactivation rate was observed. Our studies indicate that both reversible and irreversible inhibition of the inducible .NO synthease can be achieved with relatively simple modifications of the substrate L-arginine.
引用
收藏
页码:1137 / 1144
页数:8
相关论文
共 50 条
[1]   ACTIVATED MACROPHAGE CONDITIONED MEDIUM - IDENTIFICATION OF THE SOLUBLE FACTORS INDUCING CYTOTOXICITY AND THE L-ARGININE DEPENDENT EFFECTOR MECHANISM [J].
AMBER, IJ ;
HIBBS, JB ;
PARKER, CJ ;
JOHNSON, BB ;
TAINTOR, RR ;
VAVRIN, Z .
JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 49 (06) :610-620
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   ISOLATION OF NITRIC-OXIDE SYNTHETASE, A CALMODULIN-REQUIRING ENZYME [J].
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :682-685
[4]   CLONED AND EXPRESSED NITRIC-OXIDE SYNTHASE STRUCTURALLY RESEMBLES CYTOCHROME-P-450 REDUCTASE [J].
BREDT, DS ;
HWANG, PM ;
GLATT, CE ;
LOWENSTEIN, C ;
REED, RR ;
SNYDER, SH .
NATURE, 1991, 351 (6329) :714-718
[5]   PREPARATION OF NG-MONOETHYL-L-ARGININE [J].
CHO, YB ;
FURST, G ;
PAIK, WK .
ANALYTICAL BIOCHEMISTRY, 1984, 139 (02) :377-382
[6]   NG-METHYLATED ARGININES - CONVENIENT PREPARATION OF NG-METHYLARGININE [J].
CORBIN, JL ;
REPORTER, M .
ANALYTICAL BIOCHEMISTRY, 1974, 57 (01) :310-312
[7]   NITRIC-OXIDE MEDIATES GLUTAMATE NEUROTOXICITY IN PRIMARY CORTICAL CULTURES [J].
DAWSON, VL ;
DAWSON, TM ;
LONDON, ED ;
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6368-6371
[8]   MECHANISM OF OXYGEN ACTIVATION BY PTERIDINE-DEPENDENT MONOOXYGENASES [J].
DIX, TA ;
BENKOVIC, SJ .
ACCOUNTS OF CHEMICAL RESEARCH, 1988, 21 (03) :101-107
[9]   NITRIC-OXIDE SYNTHASE - IRREVERSIBLE INHIBITION BY L-NG-NITROARGININE IN BRAIN INVITRO AND INVIVO [J].
DWYER, MA ;
BREDT, DS ;
SNYDER, SH .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 176 (03) :1136-1141
[10]   CORRELATION BETWEEN NITRIC-OXIDE FORMATION DURING DEGRADATION OF ORGANIC NITRATES AND ACTIVATION OF GUANYLATE-CYCLASE [J].
FEELISCH, M ;
NOACK, EA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1987, 139 (01) :19-30